US Broker Ratings

Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Player with 11.68% Upside Potential

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, has established itself as a leading manufacturer and supplier of single-use medical devices. With a market capitalization of $5.69..

Charles River Laboratories (CRL): Investor Outlook Reveals 17.46% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $8.7 billion,..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Reveals 35.71% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing investor attention with its innovative focus on treating metabolic dysfunction-associated steatohepatitis (MASH). The company’s flagship product,..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a Promising 54.93% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing investor attention with its remarkable potential upside of 54.93%, according to recent analyst ratings. As a biotechnology company focused on developing treatments for..

Centene Corporation (CNC) Stock Analysis: Navigating Uncertainty with Strategic Healthcare Plans

Centene Corporation (NYSE: CNC), a formidable player in the healthcare sector, is currently grabbing investor attention with its strategic positioning within the healthcare plans industry. With a market capitalization of..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Modest Growth and Strategic Stability

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, is known for its innovative medical instruments and supplies, particularly in women’s health. Headquartered in Marlborough, Massachusetts, this $16.97..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus Reveals 124.98% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology sector, is garnering attention from investors due to its promising growth trajectory. With its headquarters in North Melbourne, Australia,..

Ascendis Pharma A/S (ASND) Stock Analysis: A 33% Upside Potential in the Biotech Sector

Ascendis Pharma A/S (NASDAQ: ASND) is gaining considerable attention in the biotechnology sector, primarily due to its promising pipeline and robust financial metrics. As a Denmark-based biopharmaceutical company, Ascendis focuses..

Penumbra, Inc. (PEN) Stock Analysis: A Look at Growth Potential with a 14% Upside

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors with its current market dynamics. With a..

Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, commands attention with its distinct dual-segment business model and a market capitalization of $5.66 billion. Based in Cincinnati, Ohio,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A High-Stakes Biotech Play with 31.92% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out in the biotechnology sector as a dynamic player with significant growth potential. With a market capitalization of $12.64 billion, this Carlsbad, California-based company..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating the Healthcare Sector with Strong Revenue Growth

As an integral player in the healthcare sector, Medpace Holdings, Inc. (NASDAQ: MEDP) has garnered attention for its robust growth and influential role in the diagnostics and research industry. With..

Legend Biotech Corporation (LEGN) Stock Analysis: A Lucrative 103.96% Upside in the Biotech Space

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its impressive growth potential in the biotechnology sector. As a company at the forefront of developing innovative cell..

Repligen Corporation (RGEN) Stock Analysis: Unpacking a 44% Potential Upside for Investors

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $6.99 billion, this Massachusetts-based life sciences company..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a Potential 30.92% Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL) stands out in the healthcare sector’s dynamic biotech industry, capturing investor attention with a market capitalization of $8.72 billion. This clinical-stage biopharmaceutical company is making significant..

Sanofi (SNY) Stock Analysis: Exploring a 28% Potential Upside in the Healthcare Giant

Sanofi (NYSE: SNY), a leading figure in the healthcare sector, offers a compelling investment narrative with a 28.01% potential upside, according to recent analyst ratings. This Paris-based drug manufacturer, with..

Johnson & Johnson (JNJ) Stock Analysis: Exploring a 12.22% Potential Upside Amidst Strong Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector with a market cap of $542.42 billion, remains a focal point for investors seeking stability and growth in the..

Fresenius Medical Care AG (FMS) Stock Analysis: Assessing Growth Potential with a 24% Upside

Fresenius Medical Care AG (NYSE: FMS), a leading global provider of dialysis services and products, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With its headquarters..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Uncharted Waters in the TCM Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a Hong Kong-based player in the healthcare sector, specifically focusing on the research and commercialization of Traditional Chinese Medicine (TCM) for neurocognitive disorders..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds